Planning a Clinical Development Programme for Medicines for Bronchial Asthma

The need for development of a clinical trial guidance for medicines for bronchial asthma is brought about by the improvement of requirements for research programmmes for new medicines. The aim of the study was to develop a methodological approach to conducting clinical trials of bronchial asthma medicines in Russia in line with the existing international requirements. The authors analysed regulatory documentation on the development of medicines for treatment of bronchial asthma in adults taking into account the current clinical guidelines, and specific aspects of developing medicines for treatment of bronchial asthma in children. The paper also analyses some clinical research aspects related to the development of immunotherapy. The analysis of up-to-date Russian and international clinical guidelines for bronchial asthma treatment, which are focused on bronchial asthma managementusing basic therapy, revealed the need to use revised disease concepts and new criteria to assess the efficacy of asthma medicines. The authors formulated consistent approaches to planning a clinical development programme for medicines for bronchial asthma, and suggested methodology for conducting clinical research based on recommendations of the European Medicines Agency.     

1. Omel’yanovsky VV, ed. Socio-economic burden of bronchial asthma and chronic obstructive pulmonary disease in the Russian Federation: research report for 2008–2009. Moscow: Kachestvo zhizni; 2010 (In Russ.)

2. Chuchalin AG, Khaltaev N, Antonov NS, Galkin DV, Manakov LG, Antonini P, et al. Chronic respiratory diseases and risk factors in 12 regions of the Russian Federation. Int J Chron Obstruct Pulmon Dis. 2014;(9):963–74. https://doi.org/10.2147/copd.s67283

3. Olefir YuV. The results of the analysis of materials on the safety of clinical trials. Bezopasnost’ i risk farmakoterapii = Safety and Risk of Pharmacotherapy. 2017;5(1):5–10 (In Russ.)

4. Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009;180(1):59–99. https://doi.org/10.1164/rccm.200801-060st

5. Yawn BP, Brenneman SK, Allen-Ramey FC, Cabana MD, Markson LE. Assessment of asthma severity and asthma control in children. Pediatrics. 2006;118(1):322–9. https://doi.org/10.1542/peds.2005-2576

6. Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med. 2012;18(5):716–25. https://doi.org/10.1038/nm.2678

7. Chung KF. Asthma phenotyping: a necessity for improved therapeutic precision and new targeted therapies. J Intern Med. 2016;279(2):192–204. https://doi.org/10.1111/joim.12382

8. Kurbacheva OM, Pavlova KS. Phenotypes and endotypes of bronchial asthma: from pathogenesis and clinical features to therapy. Rossiyskiy allergologicheskiy zhurnal = Russian Journal of Allergy. 2013;(1):15–24 (In Russ.)

9. Sergeeva GR, Emelyanov AV, Korovina OV, Znakhurenko AA, Leshenkova EV, Kozyreva LV, Asatiani NZ. Severe asthma: characteristics of patients in clinical practice. Terapevticheskiy arkhiv = Therapeutic Archive. 2015;87(12):26–31 (In Russ.)

10. Petrova ES, Goryachev DV, Petrov MV. Modern approaches to the assessment of orally inhaled products bioequivalence. Vedomosti Nauchnogo tsentra ekspertizy stredstv meditsinskogo primeneniya = The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. 2017;7(3):135–41 (In Russ.)

11. Siroux V, Pin I, Oryszczyn MP, Le Moual N, Kauffmann F. Relationships of active smoking to asthma and asthma severity in the EGEA study. Epidemiological study on the genetics and environment of asthma. Eur Respir J. 2000;15(3):470–7. https://doi.org/10.1034/j.1399-3003.2000.15.08.x

12. Gnoevyh VV, Smirnova AYu, Nagornov YuS, Shalashova EA, Kupriyanov AA, Portnova YuA. Bronchial asthma and smoking. MEDLINE.RU = MEDLINE.RU. 2011;12:261–89 (In Russ.)

13. Avdeev SN. ACQ questionnaire as a new tool for assessing control of asthma. Pulmonologiya = Pulmonology. 2011;(2):93–9 (In Russ.)

14. Ogorodova LM, Kobyakova OS. “ACT” — a new questionnaire for asthma control assessment. Allergologiya = Allergology. 2005;(2):50–3 (In Russ.)